Hiprex 1g tablets: Braille on outer packaging wrongly says 1mg
The Braille on the outer packaging of some batches of Hiprex 1g tablets wrongly gives the strength as 1mg, while the printed text on the packaging and leaflet correctly says 1g.
What to do
Patients need take no action and should continue to take their tablets from these batches; healthcare professionals should, if asked, explain the Braille error to patients who rely only on Braille. For questions, email regulatory@doncasterpharma.co.uk or telephone 01302 365 000.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Notice details
- Product
- Hiprex 1g tablets
- Company
- Doncaster Pharma Limited
- Hazard
- Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).
- Identifiers
- DMRC reference number: DMRC- 39194203
- Active ingredient: methenamine hippurate
- SNOMED code: 44366111000001107
- GTIN: N/A
- MHRA reference: EL(26)A/20
- Issued
- April 22, 2026
- Published on GOV.UK
- April 22, 2026
- Listed on Recalled Today
- April 22, 2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from MHRA.
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
- DMRC reference number
- DMRC- 39194203
- Marketing Authorisation Holder
- Doncaster Pharma Limited
- Medicine Details
- Hiprex 1g tablets PLPI: 56830/0284 Active ingredient: methenamine hippurate SNOMED code: 44366111000001107 GTIN: N/A
- Affected Lot Batch Numbers
- Batch No. | Expiry Date | Pack Size | First Distributed 251352/BA | 04/2028 | 100 tablets | 27/10/2025 251358/BA | 04/2028 | 100 tablets | 21/01/2026 252137/BA | 04/2028 | 100 tablets | 04/02/2026 252137/BB | 04/2028 | 100 tablets | 11/03/2026 251358/BB | 04/2028 | 100 tablets | 27/03/2026
- Background
- Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified that the embossed Braille text on the outer packaging incorrectly states the strength as 1mg. The printed text on the outer packaging, immediate packaging and Patient Information Leaflet (PIL) correctly state the strength as 1g. Correct Braille | | Incorrect Braille The correct Braille message should read: | | The incorrect Braille message reads as: | |
- Advice for Healthcare Professionals:
- The impacted products remain within specification and there is no issue with product quality. As a result, the affected batches are not being recalled. Healthcare professionals should, if requested, explain the Braille errors to patients who rely solely on Braille when reading medicine cartons. As the products are supplied in a single strength, there is no risk of dosing errors arising from the Braille issue.
- Advice for Patients:
- No action is needed from patients, continue to take medication from these batches of tablets. The actions will be controlled by the healthcare professionals who prescribe or dispense the medication who will provide appropriate support at the time of dispensing, where required. Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .
- Additional information:
- For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk , or telephone 01302 365 000. For stock control enquiries, please email commercial@doncasterpharma.co.uk , or telephone 01302 365 000. Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information. Yours faithfully Defective Medicines Report Centre 10 South Colonnade Canary Wharf London E14 4PU Telephone +44 (0)20 3080 6574 DMRC@mhra.gov.uk
- Download document
- Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
Contains public sector information licensed under the Open Government Licence v3.0. Open Government Licence
Recalled Today is independent and is not an official government page.
Related recalls
Ocumont Eye Ointment 1% w/w: one batch missing Braille on outer carton
The outer carton of batch B0866 of Ocumont Eye Ointment 1% w/w does not have Braille because it was left out by mistake, and the notice says the quality of the ointment is not affected.